E
Edward Giovannucci
Researcher at Harvard University
Publications - 1819
Citations - 202335
Edward Giovannucci is an academic researcher from Harvard University. The author has contributed to research in topics: Cancer & Prostate cancer. The author has an hindex of 206, co-authored 1671 publications receiving 179875 citations. Previous affiliations of Edward Giovannucci include University of California, San Francisco & American Cancer Society.
Papers
More filters
Journal ArticleDOI
Harvard Report on Cancer Prevention. Volume 3: prevention of colon cancer in the United States.
C A Tomeo,Graham A. Colditz,Walter C. Willett,Edward Giovannucci,Elizabeth A. Platz,Beverly Rockhill,Hank Dart,David J. Hunter +7 more
TL;DR: The pathogenesis of this disease and the burden it presents to the United States is reviewed and modi®able risk factors for colon cancer are reviewed and the evidence for screening as a preventive measure is summarized.
Journal Article
Dietary fiber and distal colorectal adenoma in men.
Elizabeth A. Platz,Edward Giovannucci,Eric B. Rimm,Helaine Rockett,Mein J. Stampfer,Graham A. Colditz,Walter C. Willett +6 more
TL;DR: It is suggested that soluble fiber may be particularly important in reducing risk of adenomatous polyps of the distal colon and support national dietary guidelines of increasing fruit consumption.
Journal ArticleDOI
Discovery of Colorectal Cancer PIK3CA Mutation as Potential Predictive Biomarker: Power and Promise of Molecular Pathological Epidemiology
Shuji Ogino,Paul Lochhead,Edward Giovannucci,Jeffrey A. Meyerhardt,Charles S. Fuchs,Andrew T. Chan +5 more
TL;DR: Recent ‘molecular pathological epidemiology’ (MPE) research has shown that aspirin use is associated with better prognosis and clinical outcome in PIK3CA-mutated colorectal carcinoma, suggesting somatic Pik3CA mutation as a molecular biomarker that predicts response to aspirin therapy.
Journal ArticleDOI
Epidemiologic Characteristics of Prostate Cancer
TL;DR: Dietary factors appear to hold the most promise for primary prevention, but the precise factors and mechanisms need to be better understood.
Journal ArticleDOI
Interaction of estrogen therapy with calcium and vitamin D supplementation on colorectal cancer risk: reanalysis of Women's Health Initiative randomized trial.
TL;DR: Results indicate that concurrent estrogen therapy was a strong effect modifier of calcium and vitamin‐D supplementation on colorectal cancer risk, and important biological mechanisms related to the key membrane receptor megalin and estrogen‐dependent protein calbindin are discussed.